Literature DB >> 16614950

Prevalence, sociodemography, and quality of life of older versus younger patients with irritable bowel syndrome: a population-based study.

Anil Minocha1, William D Johnson, Thomas L Abell, William Chad Wigington.   

Abstract

We studied the prevalence as well as the sociodemographic characteristics and QOL of older adults (> 50 years) with irritable bowel syndrome (IBS) among the population at large and compared it to their younger counterparts'. We hypothesized that IBS is less prevalent among older persons and they suffer poorer QOL compared to younger IBS patients. A total of 1000 adults from nine sites, including a medical center, churches, and a blood bank in our metropolitan area (670 African Americans, 320 Caucasians, and 10 others), completed self-administered questionnaires providing sociodemographic information and details regarding bowel habits and associated symptoms for diagnosing the IBS based on Rome II criteria. QOL was assessed by the SF-12 questionnaire. The study database was divided into two groups, younger (< 50 years) and older (> or = 50 years). The two age groups were similar with respect to gender and household income. Ninety-five of the 1000 participants had IBS, giving a total sample prevalence of 9.5% (< 50 years, 9.9%, vs > or = 50 years, 7.6%). The prevalence of IBS was similar in the two groups irrespective of race, sex, marital status, size of household, location of residence (rural versus urban), level of educational status, and household income. Compared to the older group, there was a trend toward a higher prevalence of IBS among divorced subjects (12.7% vs 0%; P = 0.1) and those below poverty level of income (15.3% vs 7.5%; P = 0.09) in the younger subjects. In contrast, older IBS patients were more likely to attend church regularly (32.5% vs 58.8%; P < 0.05). There were no differences in history of traveler's diarrhea, food intolerance, and drug allergies between the two groups. Health care utilization was similar between the two IBS groups in terms of number of physician visits, use of prescription and alternative medications, and being disabled due to IBS. There was no difference in the overall QOL score means (27.8 vs 29.5; P = NS) or in its general health and physical functioning components. However, older IBS patients had better social functioning (9.1 vs 9.8; P < 0.05). Although in our study IBS occurred less frequently among older adults than among younger patients, the difference is not statistically significant. While IBS affects QOL at all ages, social functioning was actually better on average among older compared to younger IBS patients.

Entities:  

Mesh:

Year:  2006        PMID: 16614950     DOI: 10.1007/s10620-006-3153-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  44 in total

1.  Epidemiology of irritable bowel syndrome among African Americans as compared with whites: a population-based study.

Authors:  William Chad Wigington; William D Johnson; Anil Minocha
Journal:  Clin Gastroenterol Hepatol       Date:  2005-07       Impact factor: 11.382

2.  Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II.

Authors:  G MacQueen; J Marshall; M Perdue; S Siegel; J Bienenstock
Journal:  Science       Date:  1989-01-06       Impact factor: 47.728

3.  Irritable bowel syndrome and health-related quality of life: a population-based study in Calgary, Alberta.

Authors:  Feng Xiao Li; Scott B Patten; Robert J Hilsden; Lloyd R Sutherland
Journal:  Can J Gastroenterol       Date:  2003-04       Impact factor: 3.522

Review 4.  Irritable bowel syndrome. 10% to 20% of older adults have symptoms consistent with diagnosis.

Authors:  Eli D Ehrenpreis
Journal:  Geriatrics       Date:  2005-01

5.  Terminal ileal mucosal mast cells in irritable bowel syndrome.

Authors:  A P Weston; W L Biddle; P S Bhatia; P B Miner
Journal:  Dig Dis Sci       Date:  1993-09       Impact factor: 3.199

6.  Prevalence of gastrointestinal symptoms in the elderly: a population-based study.

Authors:  N J Talley; E A O'Keefe; A R Zinsmeister; L J Melton
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

7.  A study of irritable bowel syndrome diagnosed by Manning criteria in an African population.

Authors:  I O Olubuyide; F Olawuyi; A A Fasanmade
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

8.  Irritable bowel syndrome in the general population.

Authors:  R Jones; S Lydeard
Journal:  BMJ       Date:  1992-01-11

9.  The prevalence, symptom characteristics, and impact of irritable bowel syndrome in an asian urban community.

Authors:  Kok-Ann Gwee; Sharon Wee; Mee-Lian Wong; Damian J C Png
Journal:  Am J Gastroenterol       Date:  2004-05       Impact factor: 10.864

10.  Prevalence of irritable bowel syndrome in the French population according to the Rome I criteria.

Authors:  Gilles Bommelaer; Etienne Dorval; Philippe Denis; Pierre Czernichow; Jacques Frexinos; Alain Pelc; Alain Slama; Abdelkader El Hasnaoui
Journal:  Gastroenterol Clin Biol       Date:  2002-12
View more
  21 in total

1.  The combination of oligo- and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: Results of a randomised, placebo-controlled, double-blind, parallel group, multicentre clinical trial.

Authors:  Octavian Alexea; Vlad Bacarea; Núria Piqué
Journal:  United European Gastroenterol J       Date:  2015-10-30       Impact factor: 4.623

Review 2.  Irritable bowel syndrome: a clinical review.

Authors:  Rosa L S Soares
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

3.  The relationship between obesity and functional gastrointestinal disorders: causation, association, or neither?

Authors:  Wayne Ho; Brennan M R Spiegel
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-08

4.  Is childhood abuse or neglect associated with symptom reports and physiological measures in women with irritable bowel syndrome?

Authors:  Margaret M Heitkemper; Kevin C Cain; Robert L Burr; Sang-Eun Jun; Monica E Jarrett
Journal:  Biol Res Nurs       Date:  2010-12-30       Impact factor: 2.522

Review 5.  5-Hydroxytryptamine (serotonin) in the gastrointestinal tract.

Authors:  Michael D Gershon
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2013-02       Impact factor: 3.243

6.  The current prevalence of irritable bowel syndrome in Asia.

Authors:  Full-Young Chang; Ching-Liang Lu; Tseng-Shing Chen
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

Review 7.  Chronic illness and disordered eating: a discussion of the literature.

Authors:  Virginia M Quick; Carol Byrd-Bredbenner; Dianne Neumark-Sztainer
Journal:  Adv Nutr       Date:  2013-05-01       Impact factor: 8.701

Review 8.  The burden of IBS: looking at metrics.

Authors:  Brennan M R Spiegel
Journal:  Curr Gastroenterol Rep       Date:  2009-08

9.  Olfactory and gustatory function in irritable bowel syndrome.

Authors:  Silke Steinbach; Wolfgang Reindl; Claudia Kessel; Roland Ott; Thomas Zahnert; Walter Hundt; Petra Heinrich; Dieter Saur; Wolfgang Huber
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-12-30       Impact factor: 2.503

10.  Intestinal permeability in irritable bowel syndrome patients: effects of NSAIDs.

Authors:  Angèle P M Kerckhoffs; Louis M A Akkermans; Martin B M de Smet; Marc G H Besselink; Falco Hietbrink; Imke H Bartelink; Wim B Busschers; Melvin Samsom; Willem Renooij
Journal:  Dig Dis Sci       Date:  2009-03-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.